The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 02, 2006

Filed:

Jun. 30, 2004
Applicants:

David M. Koelle, Seattle, WA (US);

Nancy A. Hosken, Seattle, WA (US);

Christine M. Posavad, Seattle, WA (US);

Hongbo Chen, Shoreline, WA (US);

Patrick Mcgowan, Seattle, WA (US);

Inventors:

David M. Koelle, Seattle, WA (US);

Nancy A. Hosken, Seattle, WA (US);

Christine M. Posavad, Seattle, WA (US);

Hongbo Chen, Shoreline, WA (US);

Patrick McGowan, Seattle, WA (US);

Assignees:

University of Washington, Seattle, WA (US);

Fred Hutchinson Cancer Research Center, Seattle, WA (US);

Corixa Corporation, Seattle, WA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/12 (2006.01);
U.S. Cl.
CPC ...
Abstract

The invention provides HSV antigens that are useful for the prevention and treatment of HSV infection. Disclosed herein are epitopes confirmed to be recognized by T-cells derived from herpetic lesions. T-cells having specificity for antigens of the invention have demonstrated cytotoxic activity against cells loaded with virally-encoded peptide epitopes, and in many cases, against cells infected with HSV. The identification of immunogenic antigens responsible for T-cell specificity provides improved anti-viral therapeutic and prophylactic strategies. Compositions containing antigens or polynucleotides encoding antigens of the invention provide effectively targeted vaccines for prevention and treatment of HSV infection.


Find Patent Forward Citations

Loading…